Location: Nashville
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Nashville
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Phase 3 · Investigative Site US047 · Incyte Corporation · NCT06959225The PREDICT Registry:
Phase N/A · Nashville Breast Center · PreludeDx · NCT03448926A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Urology Associates · Janssen Research & Development, LLC · NCT06319820Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · Vanderbilt University Medical Center · Johns Hopkins University · NCT07059091Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
NA · Barbara Murphy · Abramson Cancer Center at Penn Medicine · NCT06125743Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · SCRI Oncology Partners · IDEAYA Biosciences · NCT07015190Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Be
Phase 1 · Vanderbilt University/Ingram Cancer Center · National Cancer Institute (NCI) · NCT06696768Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Phase 3 · Vanderbilt University Medical Center · GOG Foundation · NCT05659381Tennessee Alzheimer's Project
Phase N/A · Vanderbilt University Medical Center · Vanderbilt University Medical Center · NCT05372172A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · Sarah Cannon Research Institute - Pharmacy · Pfizer · NCT05355701A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard
Phase N/A · Vanderbilt University Medical Center · Regeneron Pharmaceuticals · NCT06693531Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Vanderbilt University/Ingram Cancer Center · National Cancer Institute (NCI) · NCT05987241A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06256588First In Human Study of CX-2051 in Advanced Solid Tumors
Phase 1 · Sarah Cannon Research Institute, LLC · CytomX Therapeutics · NCT06265688JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Phase 2 · Vanderbilt University Medical Center · PPD Development, LP · NCT06701656A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin)
Phase 1/Phase 2 · Vanderbilt University Medical Center · Eisai Inc. · NCT04300556MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Premier Orthopaedic Surgery Center - Nashville · Stryker Instruments · NCT03072927Use of CereGate Therapy for Freezing of Gait in PD
NA · Vanderbilt University Medical Center · CereGate Inc. · NCT05292794A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · K2 Medical Research - Nashville · Hoffmann-La Roche · NCT07169578A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07227311A Study of ASP1002 in Adults for Treatment of Solid Tumors
Phase 1 · SCRI Oncology Partners · Astellas Pharma Global Development, Inc. · NCT05719558Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · Vanderbilt University/Ingram Cancer Center · ECOG-ACRIN Cancer Research Group · NCT07001748Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
Phase N/A · Vanderbilt University Medical Center · Vanderbilt University Medical Center · NCT06093100A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Brian S. Biesman MD, PLLC · Ipsen · NCT07435428Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia an
Phase 3 · TriStar Medical Group Children's Specialists - Pediatric Onc · Vertex Pharmaceuticals Incorporated · NCT05477563Neural Correlates of Psychiatric Disorders
Phase N/A · Vanderbilt University Medical Center · Vanderbilt University Medical Center · NCT04725409Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Phase 1 · Vanderbilt University School of Medicine · Inhibrx Biosciences, Inc · NCT03715933Pro-social Power Training Activity for Aging and Well-being With Chronic Kidney Disease
NA · Tennessee Valley Healthcare System Nashville Campus, Nashvil · VA Office of Research and Development · NCT06089057Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic
Phase N/A · Vanderbilt University · Eric R. Henderson · NCT06877793
Look up another city
Look up another condition